Riskpilot← Back to searchSign inGet full accessFagerberg Medical AB
ABActiveOrg 5590444021Mejramsvägen 11Medical specialists activities · NACE 8622Est. 20150 employees
Revenue 2025
SEK 213K
+51% vs 2024
EBITDA margin
60.6%
+169% vs 2024
Equity ratio
95.2%
Financial strength
Net profit 2025
SEK 104K
+162% vs 2024
| Revenue | SEK 213K | +51% |
| EBITDA | SEK 129K | +169% |
| Net profit | SEK 104K | +162% |
| Total assets | SEK 249K | +57% |
| Equity | SEK 237K | +78% |
| Employees | 0 | — |
Legal name
Fagerberg Medical AB
Org number
5590444021
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
23 december 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är specialistverksamhet inom öppenvård på sjukhus, stödverksamhet för utbildningsväsendet, hyrläkaruppdrag, utbildning inom sjukvård, äga och förvalta fast och lös egendom och därmed förenlig verksamhet.
Address
Mejramsvägen 11
Email
david.fagerberg@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 112 | 57 | 548 | 141 | 213 |
| Staff expenses | — | — | −12 | −41 | −29 |
| EBITDA | 61 | 45 | 482 | 48 | 129 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 61 | 45 | 482 | 48 | 129 |
| Net financials | — | — | 0 | 2 | 1 |
| Profit before tax | 61 | 45 | 483 | 50 | 130 |
| Tax | −10 | −9 | −102 | −10 | −27 |
| Net profit | 51 | 36 | 381 | 39 | 104 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 159 | 170 | 620 | 159 | 249 |
| Equity | 127 | 163 | 444 | 133 | 237 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 32 | 7 | 176 | 26 | 12 |
| Total debt | 32 | 7 | 176 | 26 | 12 |
EBITDA margin
60.6%
This company
15.8%
Market median
+284% vs market
20212025
Equity ratio
95.2%
This company
38.2%
Market median
+149% vs market
20212025
Return on equity
43.7%
This company
18.4%
Market median
+138% vs market
20212025
Net profit margin
48.7%
This company
8.1%
Market median
+501% vs market
20212025
Asset turnover
0.85×
This company
1.12×
Market median
+24% vs market
20212025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Fagerberg Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| David Lennart Fagerberg | Board of Directors | 0 companies |
| Emelie Sofie Sörqvist Fagerberg | Deputy Board Member | 0 companies |